Physical Exercise to Prevent Mild-cognitive Impairment in Patients With Kidney Disfunctions

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorBiogem s.c.ar.l.

About this trial

This research project focuses on improving memory and thinking (cognitive function) in people with advanced chronic kidney disease (CKD), a condition that affects about 10% of adults and is often linked to cognitive problems. The study includes a clinical trial where patients will either receive standard care or follow a home-based exercise program involving walking and strength training, to see if regular physical activity can improve brain function. It also includes a large-scale analysis of data from the UK Biobank to explore blood and genetic markers, brain imaging, and lifestyle factors linked to cognitive health. The ultimate aim is to find effective, easy-to-implement strategies and early warning signs that could lead to better treatment and quality of life for people living with CKD.

Eligibility criteria

Qualifiers

CKD at KDOQI stage 4-5

concomitant MCI (MOCA - MMSE (17 < MoCA < 26) or (16 < MMSE < 24)

Disqualifiers

Absolute contraindication to exercise training (e.g. unstable angina, major amputation, severe heart failure, etc.)

Known life expectancy < 6-month

Uncorrected anemia (Hb <9 g/dl)

Non-provision of informed consent

Trial design

Treatments tested in this trial

  • Exercise
  • Control (Standard treatment)

Treatment groups

124 Participants
are divided into 2 treatment groups

Sponsors and collaborators